AR and prostate cancer: Additional findings within prostate cancer showed that overexpression of AR leads to cells undergoing EMT, and overexpression of AR splice variant 7 (AR-V7), a constitutively active AR variant, (Figure 1) not only led to EMT but also to stem cell gene signatures further supporting a role for AR in EMT and metastases [19].